INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/05/2025
Back to search
Official data from USPTO
IRIS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
82
Latest update
12/06/2025
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
04/09/2015
Registration date
12/26/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2024
Last transaction
12/06/2025
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
LA GAUDE, FR
Examiner
HAYES,GINA CLARK
Current location
Historical data usage
Mark description
The mark consists of a logo, itself consisting of several geometric shapes; the middle of the logo is superimposed over one of the angles of each other geometric shape and is represented by a pink triangle shaded from the lightest at the top to the darkest at the bottom; The top left shape consists of five angles including a right angle on the upper left side and is in turquoise blue shaded from the darkest at the top left to the lightest at the bottom right; the top right shape consists of five angles including a rounded angle on the upper right side and is in orange shaded from the darkest at the top right to the lightest at the bottom left; The lower shape is central and consists of five angles including a rounded angle on the lower left corner and a right angle on the lower right and is in blue shaded from the darkest in the right to the lightest on the left; The words "IRIS PHARMA" are written in grey to the right of the geometric logo described above; The word "IRIS" is written in stylized font in lower case letters; below the word "IRIS" is the word "PHARMA" in standard font in capital letters.
Holders and representatives
Holders
I. P. (pessoa física)
I. P. (pessoa física)
Representatives
Mary L. Grieco Olshan Frome Wolosky LLP
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of eye diseases; chemical preparations for ophthalmic use; diagnostic preparations for ophthalmic use; biological preparations for the treatment of ophthalmic and eye diseases; biomarking reagents for diagnosis for ophthalmic purposes; medicines for humans for the treatment of ophthalmic conditions; eye-washes; contact lens cleaning preparations
Class 35
Marketing studies and research for business purposes for others in the pharmaceuticalparapharmaceutical and veterinary fields for ophthalmic purposes
Class 42
Clinical trials for others in the field of pharmaceuticals for ophthalmic purposes; pre-clinical testing for others in the pharmaceuticalparapharmaceutical and veterinary fields for ophthalmic purposes; in-vitro testing services for others in the pharmaceuticalparapharmaceutical and veterinary fields for ophthalmic purposes; specialized scientific laboratory services in the pharmaceuticalparapharmaceutical and veterinary fields for ophthalmic purposes; scientific research and studies in the field of eye disease; medicalpharmacologicalbiological and chemistry studies and research; research and development of new medical devicespharmaceuticalveterinary and parapharmaceutical products for others; consulting in the medical and scientific research in the field of eye disease; biologicalchemical and pharmacological analysis of pharmaceutical and parapharmaceutical and veterinary products for eye purposes
Publications
History of USPTO decisions and trademark events.
82 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/27/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
10/27/2025
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/27/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/05/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/17/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/28/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/05/2024
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
10/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/31/2023
ES71
TEAS SECTION 71 RECEIVED
09/18/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/26/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/13/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/19/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2018
FIMP
FINAL DISPOSITION PROCESSED
04/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/26/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
12/26/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/19/2017
CHPB
POST PUBLICATION AMENDMENT - ENTERED
10/03/2017
APET
ASSIGNED TO PETITION STAFF
10/02/2017
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/07/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/10/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/21/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2017
PUBO
PUBLISHED FOR OPPOSITION
07/11/2017
GPNX
NOTIFICATION PROCESSED BY IB
07/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/05/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/05/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/21/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2017
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
06/06/2017
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
06/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/05/2017
ALIE
ASSIGNED TO LIE
05/05/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/05/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/05/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/05/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2017
GNRT
NON-FINAL ACTION E-MAILED
05/05/2017
CNRT
NON-FINAL ACTION WRITTEN
05/05/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/03/2017
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
04/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/27/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/29/2016
GNRT
NON-FINAL ACTION E-MAILED
08/29/2016
CNRT
NON-FINAL ACTION WRITTEN
08/29/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2016
RFNT
REFUSAL PROCESSED BY IB
04/01/2016
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
03/28/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/10/2016
GNRT
NON-FINAL ACTION E-MAILED
02/10/2016
CNRT
NON-FINAL ACTION WRITTEN
02/10/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/10/2016
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/05/2016
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
01/22/2016
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/08/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/27/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/16/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2015
RFNT
REFUSAL PROCESSED BY IB
09/12/2015
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/21/2015
RFRR
REFUSAL PROCESSED BY MPU
08/21/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/21/2015
CNRT
NON-FINAL ACTION WRITTEN
08/20/2015
DOCK
ASSIGNED TO EXAMINER
08/19/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/13/2015
Continuous trademark protection
Get notified about every new filing that threatens IRIS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.